<div id="readability-page-1"><div><div><p>Merck and Siemens have signed a new partnership to accelerate AI for drug development</p><p>Projects include the development of AI-based tools and digital interfaces to simplify complex scientific processes</p><p>The agreement covers the provision of integrated software solutions, systems, and consumables that leverage automation, data, and AI to connect discovery, development, and commercialization of drugs.</p><p>Through this collaboration with Siemens, we are opening up new possibilities for scientists to move more quickly from an idea in the lab to a treatment for patients, Marck said. </p><p>We are partnering with Merck to provide scientists around the world with the tools they need to accelerate the development of vital medicines, Siemens said.</p></div></div></div>

默克

西門子公司

西門子(ADR)

<p>西門子和默克已建立合作關係，以增強藥物開發中的人工智能。此次合作旨在創建基於人工智能的工具和數字接口，以簡化科學流程。該協議包括集成軟件解決方案和系統，利用自動化和數據連接藥物發現、開發和商業化。預計這一合作將幫助科學家加快從實驗室創意到患者治療的轉變</p>

西門子與默克合作，加速藥物的發現和開發